EUVIMEDEUVIMED entdecken
Crossref

Repositioning Tacrolimus: Evaluation of the Effect of Short-Term Tacrolimus Treatment on Osteoprogenitor Cells and Primary Cells for Bone Regenerative Engineering

Edward O'Neill, Komal Rajpura, Erica J Carbone, Guleid Awale, Ho-Man Kan, Kevin W-H Lo

ASSAY and Drug Development Technologies · 2019-03 · 17 (2) · 77-88

DOI: 10.1089/adt.2018.876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2019-03. Verfasst von Edward O'Neill und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1 Institute for Regenerative Engineering, University of Connecticut Health Center, School of Medicine, Farmington, Connecticut. Hauptthemen laut MEDLINE: Tissue Engineering. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Engineering3T3 CellsAnimalsBone RegenerationCell ProliferationCells, CulturedDose-Response Relationship, DrugHumansImmunosuppressive AgentsMesenchymal Stem CellsMiceMolecular StructureOsteogenesisRegenerative MedicineStructure-Activity RelationshipTacrolimus

Stichwörter der Autor:innen

bone regenerationdrug deliverydrug repositioningregenerative engineeringsmall moleculestacrolimus

Substanzen

Immunosuppressive AgentsTacrolimus

Autor:innen und Institutionen

  • 1 Institute for Regenerative Engineering, University of Connecticut Health Center, School of Medicine, Farmington, Connecticut.
  • 2 The Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, University of Connecticut Health Center, School of Medicine, Farmington, Connecticut.
  • 3 Division of Endocrinology, Department of Medicine, University of Connecticut Health Center, School of Medicine, Farmington, Connecticut.
  • 4 Connecticut Institute for Clinical and Translational Science, University of Connecticut Health Center, Farmington, Connecticut.
  • 5 UConn Stem Cell Institute, University of Connecticut Health Center, Farmington, Connecticut.
  • 6 Department of Orthopaedic Surgery, University of Connecticut Health Center, School of Medicine, Farmington, Connecticut.

Zitieren

APA

O'Neill, E., Rajpura, K., Carbone, E. J., Awale, G., Kan, H. M., & Lo, K. W. (2019). Repositioning Tacrolimus: Evaluation of the Effect of Short-Term Tacrolimus Treatment on Osteoprogenitor Cells and Primary Cells for Bone Regenerative Engineering. ASSAY and Drug Development Technologies, 17(2), 77-88. https://doi.org/10.1089/adt.2018.876

Vancouver

O'Neill E, Rajpura K, Carbone EJ, Awale G, Kan HM, Lo KW. Repositioning Tacrolimus: Evaluation of the Effect of Short-Term Tacrolimus Treatment on Osteoprogenitor Cells and Primary Cells for Bone Regenerative Engineering. ASSAY and Drug Development Technologies. 2019;17(2):77-88. doi:10.1089/adt.2018.876

BibTeX
@article{ONeill2019,
  author = {O'Neill, Edward and Rajpura, Komal and Carbone, Erica J and Awale, Guleid and Kan, Ho-Man and Lo, Kevin W-H},
  title = {Repositioning Tacrolimus: Evaluation of the Effect of Short-Term Tacrolimus Treatment on Osteoprogenitor Cells and Primary Cells for Bone Regenerative Engineering},
  journal = {ASSAY and Drug Development Technologies},
  year = {2019},
  volume = {17},
  number = {2},
  pages = {77--88},
  doi = {10.1089/adt.2018.876}
}
Kostenlos starten →